Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
NCT00102375
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
900
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
Topotecan
Sponsor
AGO Study Group